Illumina, Inc. (ILMN) is a Healthcare company in the Diagnostics & Research industry with a 80% Strong Buy Score. Key strengths include Gross Margin (68.2%), Net Margin (19.6%), Return on Equity (33.4%). Our AI evaluates 8 fundamental categories including revenue growth, margin quality, balance sheet strength, cash flow generation, return on capital, and valuation metrics.
This analysis is generated by StrongBuyAnalytics AI using publicly available financial data from SEC filings, earnings reports, and market feeds. It is not personalized investment advice. See our methodology and disclaimer.
See how our AI analyzes ILMN fundamentals to generate buy/sell signals and Strong Buy Scores.
Our AI evaluates Illumina, Inc.'s fundamentals across multiple dimensions. Here is what is driving the current Strong Buy rating:
Key developments and data points that may impact Illumina, Inc.'s trajectory:
How Illumina, Inc. stacks up against comparable Healthcare companies on key metrics:
Every investment carries risk. Here are the specific risk factors our analysis identified for Illumina, Inc.:
Generate the full PDF report for a detailed risk-reward framework and bear-case scenarios.
A snapshot of Illumina, Inc.'s financial health based on the most recent filings:
Data sourced from the latest SEC filings. Generate the full PDF report for detailed balance sheet and cash flow commentary.
Based on our AI-powered fundamental analysis, ILMN has a Strong Buy Score of 80%, earning a "Strong Buy" rating. This score synthesizes 8 key financial metrics to provide an objective investment signal.
Illumina, Inc. demonstrates robust fundamentals across multiple categories. Key strengths include Gross Margin (68.2%) and Net Margin (19.6%). The stock shows characteristics typically associated with outperformers.
Our AI analyzes Illumina, Inc.'s financial statements to generate buy/sell signals based on quantitative metrics, not market sentiment or news headlines. Here's what drives the 80% score:
Generate the full PDF report for complete category-by-category scoring and AI-powered investment recommendations.
Technical traders can view real-time demand and supply zones for ILMN on our Demand Zones page. These zones identify key price levels where institutional buying or selling has historically occurred.
With ILMN currently trading at $131.81, our system monitors proximity to these critical levels and can alert you when the stock approaches support or resistance zones.
Subscribe to demand zone alerts to receive real-time notifications when ILMN reaches key technical levels.
Illumina, Inc. operates in the Healthcare sector, specifically in Diagnostics & Research. Understanding earnings trends is crucial for forecasting ILMN's trajectory.
Current revenue growth of 5.0% slightly beats the average company.
Visit our Earnings Calendar to track upcoming ILMN earnings dates and historical beat/miss patterns. Sign up for earnings alerts to get notified before announcements.
Our AI projects ILMN's trajectory based on current fundamentals and historical patterns. With a 80% Strong Buy Score, here's what the data suggests:
Bullish Outlook: Illumina, Inc. shows strong fundamental momentum. Net margins of 19.6% indicate pricing power and operational efficiency. Stocks with similar profiles have historically outperformed over 12-month periods.
For a complete 12-month price forecast with specific bull/bear scenarios, generate the full PDF report.
Understanding valuation is critical for determining if ILMN is fairly priced. Here's the current snapshot:
Our AI weighs these metrics against growth rates and margin quality to determine if ILMN offers compelling risk-adjusted returns at current prices.
Here's why investors are bullish on Illumina, Inc.:
With a 80% Strong Buy Score, the bull case is well-supported by current fundamentals. The stock exhibits characteristics of quality compounders that tend to outperform long-term.
Every investment carries risk. Here are potential concerns for ILMN investors:
The full PDF report includes a detailed bear case analysis with specific risk ratings for each category.
ILMN Summary: Illumina, Inc. earns a 80% Strong Buy Score based on AI analysis of fundamental data. Trading at $131.81 with a $20.15B market cap, the stock shows strong fundamentals supporting a bullish 12-month outlook.
Bull Case: Gross Margin (68.2%), Net Margin (19.6%)
For the complete analysis with specific price considerations, growth projections, and AI-powered buy/hold/sell recommendations, generate your free ILMN PDF report.
Deepen your understanding of the concepts used in this ILMN analysis:
Learn how to evaluate stocks using financial statements and key metrics.
Understanding P/E RatioWhat P/E ratio tells you about a stock's valuation and growth expectations.
Return on Equity (ROE)Why ROE matters for stock selection and how to interpret it.
Stock Valuation MethodsCompare DCF, P/E, and other approaches to value stocks like ILMN.
What Are Demand Zones?Find key support and resistance levels for ILMN and other stocks.
How to Read Earnings ReportsUnderstand earnings per share, revenue surprises, and guidance.
Latest SEC filings for ILMN explained in plain English — insider buys/sells (Form 4), proposed sales (Form 144), material events (8-K), and quarterly & annual reports.